Author： Rothstein David M Hartman Arthur D Cynamon Michael H Eisenstein Barry I
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.2, 2003-02, pp. : 255-271
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rifalazil of no benefit in PAD
Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. :
Access to resources
Recommend
Potential directions for drug development for osteoarthritis
Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. :
Valaciclovir:development, clinical utility and potential
By Patel R.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 2, 1997-02 ,pp. :
Vaccine Development for Potential Bioterrorism Agents
Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 3, 2003-09 ,pp. :